Where does Institute OF Organic Chemistry AND Biochemistry Ascr, V.V.I. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Institute OF Organic Chemistry AND Biochemistry Ascr, V.V.I. ranks #15,375 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

Is Institute OF Organic Chemistry AND Biochemistry Ascr, V.V.I.'s patent grant rate increasing or decreasing?

Institute OF Organic Chemistry AND Biochemistry Ascr, V.V.I.'s recent grant velocity is +25% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Institute OF Organic Chemistry AND Biochemistry Ascr, V.V.I.'s patents?

Institute OF Organic Chemistry AND Biochemistry Ascr, V.V.I.'s patents average 19.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Institute OF Organic Chemistry AND Biochemistry Ascr, V.V.I.

Q: How is the Institute OF Organic Chemistry AND Biochemistry Ascr, V.V.I. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 19 granted patents across 7 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Institute ranks #15,375 of 49,997 tracked US assignees by granted-patent volume, with 19 patents across 7 technology areas.

#15,375
of 49,997 US assignees by volume: Top 41%
by Innovation Score (38.2/100): 19.8
avg claims per patent: +25%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R15375 · Foreign Corporation #15,375 · 19 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-MICRO 19 grants
MID-PACK #15,375/49,997
PHOTO-FINISH Infinity X1
CPC-NARROW A61P · 7 areas
INNOV-THIN 38.2/100
CLAIMS-RICH 19.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +25% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Infinity X1 LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Institute’s 38.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.3 pts (27%) Velocity 6.7 pts (17%) Breadth 9.4 pts (25%) Claim depth 11.9 pts (31%)

Qualcomm Incorporated · highest

85
Institute OF… · this assignee

38
3D Lighting… · lowest

7

What this shows Institute's Innovation Score is 38.2/100 (top 41% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Institute?

Each dot is one of Institute’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Institute’s own 19.8 claims/patent is ABOVE the 12.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Institute vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Institute's grants concentrate

Institute OF Organic Chemistry AND Biochemistry Ascr, V.V.I. is a focused PatentsView assignee: 7 CPC subclasses with 84.2% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2017 (4 grants) versus a trough of 1 in 2015. By volume, Institute sits between Infinity X1 LLC and Inventure Renewables, Inc..

Institute's three-year grant acceleration

Institute OF Organic Chemistry AND Biochemistry Ascr, V.V.I. shows 6 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Infinity X1

19
Infobionic

19
Innovative Techno…

19
Institute OF Acou…

19
Instituto TecnolÓ…

19
Insys Development

19
Intelliserv

19
Inventure Renewab…

19
Institute OF Orga… ◀

19

What this shows Institute holds 19 patents at rank #15,365, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Institute

By rank, the assignees closest to #15,365 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Institute's primary technology class.

Institute's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 41% higher than 59% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Institute OF Organic Chemistry AND Biochemistry Ascr, V.V.I. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	5.3%
2017	4	21.1%
2018	1	5.3%
2019	2	10.5%
2020	1	5.3%
2021	3	15.8%
2022	2	10.5%
2023	2	10.5%
2024	2	10.5%
2025partial year	1	5.3%

Which technologies does Institute OF Organic Chemistry AND Biochemistry Ascr, V.V.I. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 16

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 15

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 10

C07D - Heterocyclic Compounds 8

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 5

C07C - Acyclic OR Carbocyclic Compounds 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Institute OF Organic Chemistry AND Biochemistry Ascr, V.V.I.'s patent record in context - here's where to go next.

Institute OF Organic Chemistry AND Biochemistry Ascr, V.V.I.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 84.2% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #15,375 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Institute OF Organic Chemistry AND Biochemistry Ascr, V.V.I. against Infinity X1 LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.